Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES HEXATRONIC IN CONJUNCTION WITH RIGHTS ISSUE AND OVERSUBSCRIPTION OPTION
Mandate

VINGE ADVISES HEXATRONIC IN CONJUNCTION WITH RIGHTS ISSUE AND OVERSUBSCRIPTION OPTION

March 02, 2015

Vinge has advised Hexatronic Group AB (publ) listed on NASDAQ Stockholm First North in conjunction with a rights issue of approximately SEK 41 million with an oversubscription option of approximately SEK 10 million, which may be exercised if the rights issue is oversubscribed. One subscription right is provided for each share in Hexatronic and six subscription rights entitle the holder to subscribe for one new share. The subscription price amounts to SEK 9 per share. It is estimated that the rights issue prospectus will be published on or about 14 April 2015.

Vinge’s team consisted of responsible partner Anders Strid together with associates Frida Bäckegren, Daniel Lennartsson and corporate assistant Camilla Andersson.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025